Cargando…
2D-DIGE as a strategy to identify serum protein biomarkers to monitor pharmacological efficacy in dopamine-dictated states of Parkinson’s disease and schizophrenia
OBJECTIVES: Parkinson’s disease and schizophrenia are clinical scenarios that occur due to dopaminergic deficit and hyperactivity in the midbrain, respectively. Current pharmacological interventions for these two diseases therefore aim to restore normal dopamine levels in the midbrain. But during th...
Autores principales: | Gupta, Ashish Kumar, Kumar, Gaurav Khunger, Rani, Komal, Pokhriyal, Ruchika, Khan, Mohd Imran, Kumar, Domada Ratna, Goyal, Vinay, Tripathi, Manjari, Gupta, Rishab, Chadda, Rakesh Kumar, Vanamail, Perumal, Mohanty, Ashok Kumar, Hariprasad, Gururao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6488160/ https://www.ncbi.nlm.nih.gov/pubmed/31114209 http://dx.doi.org/10.2147/NDT.S198559 |
Ejemplares similares
-
Evaluation of Serum Apolipoprotein E as a Potential Biomarker for
Pharmacological Therapeutic Efficacy Monitoring in Dopamine Dictated Disease
Spectrum of Schizophrenia and Parkinson’s disease: A Preliminary
Study
por: Gupta, Ashish Kumar, et al.
Publicado: (2018) -
Cerebrospinal Fluid Proteomics For Identification Of α2-Macroglobulin As A Potential Biomarker To Monitor Pharmacological Therapeutic Efficacy In Dopamine Dictated Disease States Of Parkinson’s Disease And Schizophrenia
por: Gupta, Ashish Kumar, et al.
Publicado: (2019) -
Evaluation of α-synuclein and apolipoprotein E as potential biomarkers in cerebrospinal fluid to monitor pharmacotherapeutic efficacy in dopamine dictated disease states of Parkinson’s disease and schizophrenia
por: Gupta, Ashish Kumar, et al.
Publicado: (2019) -
Comparative Proteomic Analysis of Advanced Ovarian Cancer Tissue to Identify Potential Biomarkers of Responders and Nonresponders to First-Line Chemotherapy of Carboplatin and Paclitaxel
por: Sehrawat, Urmila, et al.
Publicado: (2016) -
Chemotherapy Resistance in Advanced Ovarian Cancer Patients
por: Pokhriyal, Ruchika, et al.
Publicado: (2019)